# PHASE 5 IMPLEMENTATION READINESS DECISION RECORD

**Version: v12.0 — LOCKED**

Status: **LOCKED — v12.0 — consolidated through Task #009 closeout / Phase 5 closure milestone**

---

# 1. Purpose

This is the consolidated Phase 5 Implementation Readiness Decision Record, using the v6.0 structure and terminology as the authoritative format.

This v12.0 update is the **single post-v11.0 synchronization** following completion of Task #009 implementation, technical acceptance, remote verification, and formal closeout.

No intermediate IR artifact/version was created between v11.0 and v12.0.

---

# 2. Phase 5 Current Implementation State

| Task | Status | Commit |
|---|---|---|
| #002 | CLOSED / PASS | `c98d170` |
| #003 | CLOSED / PASS | `f197b80` |
| #004 | CLOSED / PASS / REMOTE VERIFIED | `c28b498` |
| #005 | CLOSED / PASS / REMOTE VERIFIED | `c5540dd` |
| #006 | CLOSED / PASS / REMOTE VERIFIED | `9116213` |
| #007 | CLOSED / PASS / REMOTE VERIFIED | `8fdf222` |
| #008 | CLOSED / PASS / REMOTE VERIFIED | `973b351` |
| #009 | CLOSED / PASS / REMOTE VERIFIED | `0f413c9` |

Authoritative branch:

`phase5/task002-scaffolding`

Task #009 remote:

`origin/phase5/task002-scaffolding → 0f413c94ce3848c586fc3fd500706017c82d7533`

`origin/main` remains:

`71e84f3514d35d76c53a36b48d7a14220c4d633e`

---

# 3. Locked Phase 5 Working Method

**Batch decisions → approval → lock → Implementation Specification → Claude implementation → patch export → ChatGPT review → VS Code/local Git apply → verification → controlled staging → staged review → commit → push → remote verify → closeout**

Claude is the implementation/testing/patch-export executor.

ChatGPT is the strategy, governance, task-specification, review and acceptance authority.

VS Code/local Git is the controlled integration/commit/push/remote-verification layer.

`git add .` is prohibited for controlled task closeout.

---

# 4. Phase 5 Architectural State After Task #009

```text
Repository
  ↓
Population / PP
  ↓
canonical Gold artifacts
  ↓
Safety Enforcement / Authorization
  ↓
Retrieval
  ↓
Runtime Evidence Package
  ↓
Runtime Integration
  ↓
GenerationContext
  ↓
Generation
  ↓
Candidate Response
  ↓
Validation
  ↓
ValidationResult
  ↓
governed downstream delivery remains outside Phase 5 implementation scope
```

Task #009 establishes the governed Safety Enforcement / Authorization boundary before normal medical retrieval.

Locked architectural principle:

**Authorization and safety routing precede Retrieval.**

Restrictive Safety Decisions cannot be overridden by downstream Retrieval, Generation or Validation.

---

# 5. Task #009 Architecture / Scope Gate — Consolidated

**B1–B4 APPROVED / LOCKED**

Task #009 establishes the governed Safety Enforcement / Authorization boundary before normal medical retrieval.

## B1 — Safety Enforcement Boundary

**APPROVED / LOCKED**

- Authorization and safety routing precede Retrieval.
- The Safety boundary returns a governed Safety Decision.
- Safety does not perform Retrieval, evidence assembly, Runtime Integration, Generation or Validation.
- Scope is limited to authorization/safety routing, risk classification, restricted/prohibited handling, emergency routing, deterministic action selection and traceability.

## B2 — Authorization / Risk / Safety Action Contract

**APPROVED / LOCKED**

Risk vocabulary:

- `LOW`
- `MODERATE`
- `HIGH`
- `EMERGENCY`

Safety Action vocabulary:

- `ALLOW`
- `ALLOW_WITH_WARNING`
- `ASK_CLARIFICATION`
- `REDIRECT`
- `ESCALATE`
- `REJECT`

Locked principles:

- unresolved safety state defaults to deny;
- emergency precedence applies;
- prohibited capabilities cannot be allowed;
- individualized high-risk clinical requests receive controlled restriction;
- decisions are deterministic and policy-versioned;
- downstream layers cannot override restrictive Safety Decisions.

## B3 — Safety Failure / Escalation / Termination Semantics

**APPROVED / LOCKED**

- `REJECT` terminates normal execution with no Retrieval, Generation or automatic delivery.
- `ESCALATE` terminates automated clinical answering/completion.
- `ASK_CLARIFICATION` terminates the current execution; new information requires fresh evaluation.
- `REDIRECT` terminates the unsafe route; a new route requires fresh Safety Enforcement evaluation.
- `EMERGENCY` terminates the normal pipeline.
- Safety-engine failure is fail-closed and never defaults to `ALLOW`.
- Escalation failure never falls back to `ALLOW`.
- Restrictive actions cannot automatically recover to `ALLOW`.
- Validation success cannot override a restrictive Safety Decision.

## B4 — Implementation Surface + Tests + E2E Acceptance

**APPROVED / LOCKED**

Implementation surface:

`08_Development/implementation/src/safe_medical_ai/safety/`

Tests:

`08_Development/implementation/tests/test_safety_models.py`

`08_Development/implementation/tests/test_safety_enforcement.py`

Acceptance covers typed models, authorization/risk, emergency/prohibited handling, six-action semantics, fail-closed behavior, escalation, traceability, cross-boundary behavior, E2E enforcement and regression/scope verification.

---

# 6. Task #009 Cross-Boundary Invariants

**LOCKED**

```text
ALLOW
    → normal Phase 5 pipeline may proceed

ALLOW_WITH_WARNING
    → normal pipeline may proceed with warning preserved

ASK_CLARIFICATION
    → terminate current execution

REDIRECT
    → terminate unsafe route; fresh Safety evaluation required

ESCALATE
    → terminate automated normal delivery

REJECT / EMERGENCY
    → terminate normal pipeline
```

No downstream layer may transform a restrictive Safety Decision into `ALLOW`.

Task #008 `VALID` cannot override a restrictive Safety Decision.

---

# 7. Task #009 Implementation / Technical Acceptance

**CLOSED / PASS / REMOTE VERIFIED**

Implemented:

- isolated `safety/` package;
- typed Safety models;
- deterministic Safety Enforcement boundary;
- fail-closed behavior;
- risk/action semantics;
- escalation/termination semantics;
- traceability/policy-version handling;
- E2E enforcement tests.

R1 refinement:

The E2E tests were refined to use the real existing downstream `InMemoryRepositorySource` / `RetrievalService` boundary and the real Task #008 `validate_candidate_response()` path rather than a synthetic downstream pipeline.

Verification:

- Dedicated Task #009 tests: **47/47 PASS**
- Full implementation regression: **287/287 PASS**
- one pre-existing unrelated Starlette/httpx deprecation warning only;
- `git diff --check`: **PASS**
- Task #003–#008 implementation paths: **untouched**
- Governance/project-management materials: **not included in Task #009 commit**
- staged Task #009 surface: **6 files**
- controlled commit: `0f413c9`
- push: **PASS**
- local HEAD = origin branch = remote SHA:
  `0f413c94ce3848c586fc3fd500706017c82d7533`

Task #009 therefore:

**CLOSED / PASS / REMOTE VERIFIED**

---

# 8. Phase 5 Technical / Clinical-Safety Validation Disposition

The approved Phase 5 Clinical/Safety Validation B1–B4 were completed before Task #009 implementation and are consolidated here as the final gate evidence.

## B1 — Clinical Governance & Scope Validation

**APPROVED / LOCKED**

The governed Safety boundary is explicitly separated from clinical reasoning, evidence retrieval and final clinical approval. Scope remains bounded to authorization, risk, safety action and routing semantics.

## B2 — Evidence Fidelity, Provenance & Insufficiency Validation

**APPROVED / LOCKED**

The runtime chain preserves authoritative evidence/provenance semantics. Safety enforcement does not fabricate, enrich, repair or reinterpret RTEP evidence and does not become a retrieval/evidence authority.

## B3 — Safety / Failure / Escalation Validation

**APPROVED / LOCKED**

Failure, escalation, termination, default-deny and restrictive-action semantics are explicit. No restrictive Safety action may silently recover to `ALLOW`; no validation success may override Safety.

## B4 — End-to-End Clinical Safety Acceptance & Regression

**APPROVED / LOCKED**

Task #009 E2E enforcement plus full regression demonstrate that restrictive Safety actions block/divert downstream execution while `ALLOW` permits normal continuation.

This is **engineering-level clinical/safety enforcement validation**, not real-world clinical validation or patient-specific medical safety approval.

---

# 9. Phase 5 Closure Gate

**STATUS: CLOSED / PASS**

The final implementation chain now contains the Phase 5-governed runtime boundaries required by the approved Phase 5 scope:

- Retrieval;
- Runtime Evidence Package;
- Runtime Integration;
- Generation;
- Validation;
- Safety Enforcement / Authorization preceding Retrieval.

The remaining items explicitly excluded by the Phase 5 scope are not treated as unresolved Phase 5 defects.

They remain future lifecycle/deployment concerns, including:

- production deployment;
- production LLM/provider selection;
- production safety infrastructure;
- monitoring;
- UI;
- human approval workflow;
- patient-specific clinical safety adjudication;
- unrestricted external web retrieval;
- semantic/vector retrieval and production database infrastructure.

**No Task #010 is authorized or required merely for continuation.**

A future task is justified only by a newly identified genuine architecture-level gap and must pass a new Architecture / Scope Gate.

---

# 10. Recording / Handover Rules — LOCKED

This v12.0 record is the **single consolidated update after Task #009 implementation, technical acceptance and closeout**.

No IR artifact was updated between individual Task #009 batch approvals.

The next update is permitted only at a new governance milestone, package close, phase close or thread/phase handover.

---

# 11. Amendment History

## Version 6.0
Task #005 specification close; B1–B4 locked.

## Version 7.0
Task #005 implementation closeout.

## Version 8.0
Task #006 B1–B4 locked.

## Version 9.0
Task #006 implementation closeout.

## Version 10.0
Task #007 implementation closeout.

## Version 11.0
Task #008 implementation closeout and Technical Validation / Acceptance Gate closeout. Consolidated Task #008 B1–B4, Technical Validation B1–B4, **240/240 PASS**, and established the Phase 5 closure decision point.

## Version 12.0
Updated once at **Task #009 closeout / Phase 5 closure milestone**.

Major updates:

- recorded Task #009 Architecture / Scope B1–B4 as APPROVED / LOCKED;
- recorded Task #009 Safety Enforcement implementation and R1 E2E refinement;
- recorded **47/47 dedicated Task #009 tests PASS**;
- recorded **287/287 full regression PASS**;
- recorded `git diff --check` PASS;
- recorded Task #003–#008 scope integrity;
- recorded authoritative Task #009 commit `0f413c9`;
- recorded remote verification at `0f413c94ce3848c586fc3fd500706017c82d7533`;
- consolidated the approved Clinical/Safety Validation B1–B4;
- formally closed Task #009;
- formally closed the Phase 5 Closure Gate;
- confirmed that no additional numbered task is required merely to continue the sequence.

**PHASE 5: CLOSED / PASS — IMPLEMENTATION / TECHNICAL / GOVERNANCE SCOPE ACHIEVED.**
